A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to be notified if that changes.
Chloroquine malaria treatment is a medication approved to prevent and treat malaria infection. It can also be prescribed to treat extraintestinal amebiasis.
Chloroquine is an anti-infective agent that works by binding to DNA and RNA polymerase in parasites. By blocking these proteins, chloroquine interferes with normal parasite metabolism. It also concentrates within the acid vesicles of parasites, causing a pH shift that impairs their growth.
The dosage of chloroquine depends on what is being treated. Take chloroquine exactly as prescribed by your doctor.
The usual doses are:
Chloroquine is available in Chloroquine 250 mg and Chloroquine 500 mg.
The active ingredient in Chloroquine is chloroquine phosphate.
Significant drug-drug interactions exist with chloroquine. Tell your doctor about any medications you are taking, including:
Tell your doctor if you have a history of kidney, liver, or heart disease.
Chloroquine can cause severe hypoglycemia (low blood sugar).
Chloroquine has many precautions. Speak with your doctor before starting this medication.
Common side effects may include:
Drug [package insert]. Eatontown, NJ: Westward; 2009.